Al Khuwaitir Tarig S, Wani Bashir A, Dawood Helmi A, Khan Mohammed A
Riyadh Medical Complex, PO Box 3847, Riyadh 11481, Kingdom of Saudi Arabia.
Saudi Med J. 2005 Jan;26(1):130-2.
Thrombolytic therapy is the modality of choice for the treatment of life threatening thrombosis in various vascular territories and nowadays, is used extensively in setting of acute myocardial infarction. There is, however, the omnipresent danger of serious bleeding inherently associated with the use of all thrombolytics which if it occurs in the brain, can lead to potentially serious neurological impairment and even death. In our report, we describe the successful surgical management of a streptokinase-induced intracranial hemorrhage. Timely neurosurgical intervention is advocated as the optimal approach for this particular side effect of thrombolytic agents.
溶栓治疗是治疗各种血管区域危及生命的血栓形成的首选方式,如今在急性心肌梗死的治疗中被广泛应用。然而,使用所有溶栓药物都存在不可避免的严重出血风险,如果发生在脑部,可能导致潜在的严重神经功能损害甚至死亡。在我们的报告中,我们描述了一例链激酶诱发的颅内出血的成功手术治疗。对于溶栓药物的这种特殊副作用,提倡及时进行神经外科干预作为最佳治疗方法。